|Last Price$74.16||Day Change (%)-0.31%|
|Open Price$73.71||Day Change ($)-0.23|
|Day Range73.49–74.35||52-Week Range57.00–77.92|
As of Fri 9/30/2016 5:27:00 PM | USD
Senator Pete Domenici Announces Solution for Oklahoma Earthquakes is in IX Power’s Produced Water Treatment from Los Alamos
Fitch Rates Jamestown CLO IX Ltd./Corp.
Kadmon Initiates Placebo-Controlled Phase 2 Clinical Trial Evaluating KD025 in Psoriasis
Acadia Realty Trust to Present at the Bank of America Merrill Lynch 2016 Global Real Estate Conference
Algonquin Power & Utilities Corp. and The Empire District Electric Company Announce Missouri Public Service Commission Authorization of Merger Transaction; Motion to Amend Kansas Procedural Schedule
Westlake Chemical Announces Expiration and Final Results of the Exchange Offers and Consent Solicitations for Certain Axiall Notes
LifePoint Health Appoints Michael S. Coggin as Chief Financial Officer
Focus remains on hemophilia competition, but Baxter's comprehensive product portfolios are unmatched.
Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.